Brainstorm Cell Therapeutics Inc. (BCLI)
SG&A Expenses
$2.65M
Quarterly · Period ending: · USD
BCLI SG&A Expenses
Latest reported$2.65Mperiod ending
Latest reported$2.65Mperiod ending
BCLI Quarterly SG&A Expenses ($5.43K → $2.65M)
Quarterly SG&A Expenses
High-resolution chart · PNG
BCLI sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 2,650,000 | |
| 1,284,000 | |
| -4,386,000 | |
| 1,148,000 | |
| 1,453,000 | |
| 1,785,000 | |
| 1,466,000 | |
| 2,003,000 | |
| 2,060,000 | |
| 1,513,000 | |
| 3,106,000 | |
| 2,705,000 | |
| 2,655,000 | |
| 2,227,000 | |
| 2,464,000 | |
| 3,065,000 | |
| 2,478,000 | |
| 2,859,000 | |
| 2,535,000 | |
| 1,659,000 | |
| 2,522,000 | |
| 2,588,000 | |
| 2,671,000 | |
| 2,618,000 | |
| 1,706,000 | |
| 2,360,000 | |
| 1,479,000 | |
| 1,543,000 | |
| 1,303,000 | |
| 1,472,000 | |
| 1,577,000 | |
| 1,257,000 | |
| 1,606,000 | |
| 1,330,000 | |
| 1,329,000 | |
| 1,224,000 | |
| 640,000 | |
| 829,000 | |
| 327,000 | |
| 848,000 | |
| 832,000 | |
| 826,000 | |
| 571,000 | |
| 1,068,000 | |
| 988,000 | |
| 960,000 | |
| 1,025,000 | |
| 858,000 | |
| 417,000 | |
| 351,000 | |
| 527,000 | |
| 272,000 | |
| 743,000 | |
| 559,000 | |
| 351,000 | |
| 440,000 | |
| 448,000 | |
| 510,000 | |
| 746,000 | |
| 564,000 | |
| 829,000 | |
| 258,000 | |
| 642,000 | |
| 264,000 | |
| 268,000 | |
| 370,000 | |
| 686,000 | |
| 318,000 | |
| 314,000 | |
| 251,000 | |
| 201,000 | |
| 405,000 | |
| 479,000 | |
| 544,000 | |
| 920,000 | |
| 865,000 | |
| 457,000 | |
| 747,811 | |
| 1,277,502 | |
| 621,000 | |
| 632,310 | |
| 632,310 | |
| 574,844 | |
| 704,596 | |
| 542,308 | |
| 502,347 | |
| 302,706 | |
| 1,574,634 | |
| 8,698 | |
| 27,123 | |
| 8,669 | |
| 5,108 | |
| 6,333 | |
| 11,578 | |
| 11,808 | |
| 7,605 | |
| 5,433 |